{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:44:31Z","timestamp":1792226671773,"version":"4.4.0"},"reference-count":86,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1681\/asn.2012070734","type":"journal-article","created":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T00:40:50Z","timestamp":1361493650000},"page":"702-711","source":"Crossref","is-referenced-by-count":138,"title":["The Treatment of Minimal Change Disease in Adults"],"prefix":"10.1681","volume":"24","author":[{"given":"Jonathan","family":"Hogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20230208","first-page":"43","article-title":"Alterations of the glomerular epithelium in acute aminonucleoside nephrosis. Evidence for formation of occluding junctions and epithelial cell detachment.","volume":"34","author":"Caulfield","year":"1976","journal-title":"Lab Invest"},{"key":"R3-7-20230208","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: A disorder of T-cell function.","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"R4-7-20230208","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.2007080836","article-title":"Urinary CD80 excretion increases in idiopathic minimal-change disease.","volume":"20","author":"Garin","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R5-7-20230208","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00467-009-1214-x","article-title":"T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.","volume":"24","author":"Araya","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R6-7-20230208","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1681\/ASN.2007111244","article-title":"Induction of T regulatory cells attenuates idiopathic nephrotic syndrome.","volume":"20","author":"Le Berre","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R7-7-20230208","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome.","volume":"113","author":"Reiser","year":"2004","journal-title":"J Clin Invest"},{"key":"R8-7-20230208","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","article-title":"Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats.","volume":"18","author":"Lai","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R9-7-20230208","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ndt\/gfr271","article-title":"Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-\u03baB-dependent pathway.","volume":"27","author":"Shimada","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R10-7-20230208","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/ki.2010.143","article-title":"Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.","volume":"78","author":"Garin","year":"2010","journal-title":"Kidney Int"},{"key":"R11-7-20230208","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome.","volume":"17","author":"Clement","year":"2011","journal-title":"Nat Med"},{"key":"R12-7-20230208","doi-asserted-by":"crossref","first-page":"e30523","DOI":"10.1371\/journal.pone.0030523","article-title":"Upregulation of nuclear factor-related kappa B suggests a disorder of transcriptional regulation in minimal change nephrotic syndrome.","volume":"7","author":"Audard","year":"2012","journal-title":"PLoS ONE"},{"key":"R13-7-20230208","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0272-6386(97)90485-6","article-title":"Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997.","volume":"30","author":"Haas","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"R14-7-20230208","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1523-1755.2004.00831.x","article-title":"The Italian experience of the national registry of renal biopsies.","volume":"66","author":"Gesualdo","year":"2004","journal-title":"Kidney Int"},{"key":"R15-7-20230208","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1681\/ASN.V85824","article-title":"Treatment of the idiopathic nephrotic syndrome: Regimens and outcomes in children and adults.","volume":"8","author":"Tune","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R16-7-20230208","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000046215","article-title":"Adult-onset minimal change disease among Taiwanese: Clinical features, therapeutic response, and prognosis.","volume":"21","author":"Huang","year":"2001","journal-title":"Am J Nephrol"},{"key":"R17-7-20230208","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000167603","article-title":"Minimal-change glomerulopathy of adulthood.","volume":"8","author":"Korbet","year":"1988","journal-title":"Am J Nephrol"},{"key":"R18-7-20230208","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: Clinical characteristics, treatment, and outcomes.","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R19-7-20230208","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/oxfordjournals.ndt.a027136","article-title":"Long-term outcome of adult-onset minimal-change nephropathy.","volume":"11","author":"Mak","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R20-7-20230208","doi-asserted-by":"crossref","first-page":"vi52","DOI":"10.1093\/ndt\/gfg1060","article-title":"Secondary minimal change disease.","volume":"18","author":"Glassock","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R21-7-20230208","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0272-6386(12)80055-2","article-title":"Adult minimal change glomerulopathy with acute renal failure.","volume":"16","author":"Jennette","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"R22-7-20230208","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/ndt\/gfg134","article-title":"Idiopathic minimal change nephrotic syndrome in older adults: Steroid responsiveness and pattern of relapses.","volume":"18","author":"Tse","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R23-7-20230208","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ki.1986.130","article-title":"Adult-onset minimal change nephrotic syndrome: A long-term follow-up.","volume":"29","author":"Nolasco","year":"1986","journal-title":"Kidney Int"},{"key":"R24-7-20230208","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/ajkd.2003.50116","article-title":"Steroid-sensitive nephrotic syndrome: From childhood to adulthood.","volume":"41","author":"Fakhouri","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R25-7-20230208","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/bmj.3.5720.421","article-title":"Controlled trial of prednisone in adult patients with the nephrotic syndrome.","volume":"3","author":"Black","year":"1970","journal-title":"BMJ"},{"key":"R26-7-20230208","first-page":"18","article-title":"Adult minimal change nephropathy: Experience of the collaborative study of glomerular disease.","volume":"97","author":"Coggins","year":"1986","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"R27-7-20230208","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0272-6386(12)70179-8","article-title":"The nephrotic syndrome, lipids, and risk factors for cardiovascular disease.","volume":"22","author":"Radhakrishnan","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"R28-7-20230208","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1440-1754.1998.00232.x","article-title":"Prevention of serious bacterial infection in children with nephrotic syndrome.","volume":"34","author":"McIntyre","year":"1998","journal-title":"J Paediatr Child Health"},{"key":"R29-7-20230208","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: Results from a large retrospective cohort study.","volume":"117","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"R30-7-20230208","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease.","volume":"7","author":"Kerlin","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R31-7-20230208","first-page":"CD001533","article-title":"Corticosteroid therapy for nephrotic syndrome in children.","volume":"4","author":"Hodson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R32-7-20230208","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2008-1559","article-title":"Management of childhood onset nephrotic syndrome.","volume":"124","author":"Gipson","year":"2009","journal-title":"Pediatrics"},{"key":"R33-7-20230208","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1445-5994.1983.tb04479.x","article-title":"Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome.","volume":"13","author":"Yeung","year":"1983","journal-title":"Aust N Z J Med"},{"key":"R34-7-20230208","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/bmj.291.6505.1305","article-title":"Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome.","volume":"291","author":"Imbasciati","year":"1985","journal-title":"Br Med J (Clin Res Ed"},{"key":"R35-7-20230208","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jama.1958.03000040013003","article-title":"Prolonged intermittent steroid therapy for nephrosis in children and adults.","volume":"168","author":"Lange","year":"1958","journal-title":"J Am Med Assoc"},{"key":"R36-7-20230208","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000184494","article-title":"Minimal-change nephrotic syndrome in adults treated with alternate-day steroids.","volume":"47","author":"Nair","year":"1987","journal-title":"Nephron"},{"key":"R38-7-20230208","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0022-3476(88)80136-7","article-title":"Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome.","volume":"112","author":"Ueda","year":"1988","journal-title":"J Pediatr"},{"key":"R39-7-20230208","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(72)90978-6","article-title":"Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome.","volume":"1","author":"Uldall","year":"1972","journal-title":"Lancet"},{"key":"R40-7-20230208","first-page":"26","article-title":"Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis.","volume":"11","author":"Al-Khader","year":"1979","journal-title":"Clin Nephrol"},{"key":"R41-7-20230208","first-page":"461","article-title":"The nephrotic syndrome in adults with \u2018minimal change\u2019 glomerular lesions.","volume":"43","author":"Cameron","year":"1974","journal-title":"Q J Med"},{"key":"R42-7-20230208","doi-asserted-by":"crossref","first-page":"c25","DOI":"10.1159\/000085708","article-title":"Treatment with cyclophosphamide in elderly-onset nephrotic syndrome.","volume":"101","author":"Mak","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"R43-7-20230208","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2169\/internalmedicine.43.668","article-title":"Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome.","volume":"43","author":"Matsumoto","year":"2004","journal-title":"Intern Med"},{"key":"R44-7-20230208","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1053\/ajkd.2002.31400","article-title":"Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.","volume":"39","author":"Nakayama","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R45-7-20230208","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ndt\/gfp422","article-title":"Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.","volume":"25","author":"Eguchi","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R46-7-20230208","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/ndt\/gfm637","article-title":"Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.","volume":"23","author":"Li","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R47-7-20230208","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.clinthera.2012.03.008","article-title":"Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: A multicenter, open-label, nonrandomized cohort trial.","volume":"34","author":"Li","year":"2012","journal-title":"Clin Ther"},{"key":"R48-7-20230208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00868243","article-title":"Intravenous pulse cyclophosphamide\u2014a new regime for steroid-resistant minimal change nephrotic syndrome.","volume":"8","author":"Elhence","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"R49-7-20230208","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00467-003-1095-3","article-title":"Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.","volume":"18","author":"Bajpai","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"R50-7-20230208","first-page":"610","article-title":"Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.","volume":"22","author":"Ueda","year":"2009","journal-title":"J Nephrol"},{"key":"R51-7-20230208","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/ndt\/15.6.922-a","article-title":"The patient with over 100 relapses of minimal change nephrotic syndrome: Prolonged complete remission after chlorambucil treatment.","volume":"15","author":"Carre\u00f1o","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R52-7-20230208","first-page":"S37","article-title":"Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: Minimal-change disease and focal-segmental glomerulosclerosis.","volume":"35","author":"Meyrier","year":"1991","journal-title":"Clin Nephrol"},{"key":"R53-7-20230208","doi-asserted-by":"crossref","first-page":"vi79","DOI":"10.1093\/ndt\/gfg1067","article-title":"Treatment of idiopathic nephrosis by immunophillin modulation.","volume":"18","author":"Meyrier","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R55-7-20230208","first-page":"1326","article-title":"Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial.","volume":"8","author":"Ponticelli","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"R56-7-20230208","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/ki.1994.189","article-title":"Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome.","volume":"45","author":"Meyrier","year":"1994","journal-title":"Kidney Int"},{"key":"R57-7-20230208","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1016\/j.ajkd.2003.07.011","article-title":"Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome.","volume":"42","author":"Tang","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R58-7-20230208","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5414\/CNP65393","article-title":"Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome.","volume":"65","author":"Westhoff","year":"2006","journal-title":"Clin Nephrol"},{"key":"R59-7-20230208","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2009.02.018","article-title":"Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.","volume":"54","author":"Li","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R60-7-20230208","first-page":"127","article-title":"The use of enteric-coated mycophenolate sodium in the treatment of relapsing and steroid-dependent minimal change disease.","volume":"21","author":"Siu","year":"2008","journal-title":"J Nephrol"},{"key":"R61-7-20230208","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1523-1755.2002.00214.x","article-title":"Mycophenolate mofetil treatment for primary glomerular diseases.","volume":"61","author":"Choi","year":"2002","journal-title":"Kidney Int"},{"key":"R62-7-20230208","first-page":"268","article-title":"Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: Extended experience in a single center.","volume":"72","author":"Fujinaga","year":"2009","journal-title":"Clin Nephrol"},{"key":"R63-7-20230208","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/ajkd.1998.v31.pm9469489","article-title":"Successful mycophenolate mofetil treatment of glomerular disease.","volume":"31","author":"Briggs","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R64-7-20230208","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/ndt\/17.11.2011","article-title":"Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome.","volume":"17","author":"Day","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R65-7-20230208","first-page":"819","article-title":"Failure of mycophenolate mofetil therapy in primary refractory nephrotic syndrome.","volume":"19","author":"Baglio","year":"2006","journal-title":"J Nephrol"},{"key":"R66-7-20230208","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5414\/CNP69090","article-title":"Treatment of lupus nephritis and primary glomerulonephritis with enteric-coated mycophenolate sodium.","volume":"69","author":"Kitiyakara","year":"2008","journal-title":"Clin Nephrol"},{"key":"R67-7-20230208","doi-asserted-by":"crossref","first-page":"c189","DOI":"10.1159\/000199459","article-title":"Mycophenolate mofetil in high-risk patients with primary glomerulonephritis: Results of a 1-year prospective study.","volume":"111","author":"Dimkovic","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"R68-7-20230208","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1159\/000065276","article-title":"Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil.","volume":"22","author":"Mogyor\u00f3si","year":"2002","journal-title":"Am J Nephrol"},{"key":"R69-7-20230208","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.ajkd.2006.10.015","article-title":"Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: First case report and pathophysiological considerations.","volume":"49","author":"Fran\u00e7ois","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R70-7-20230208","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1093\/ndt\/gfm128","article-title":"Rituximab: Effective treatment for severe steroid-dependent minimal change nephrotic syndrome?","volume":"22","author":"Hofstra","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R71-7-20230208","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-009-1377-5","article-title":"Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.","volume":"25","author":"Fujinaga","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R72-7-20230208","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5414\/CN107092","article-title":"Rituximab in adult patients with immunosuppressive-dependent minimal change disease.","volume":"76","author":"Hoxha","year":"2011","journal-title":"Clin Nephrol"},{"key":"R73-7-20230208","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ndt\/gfm592","article-title":"Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.","volume":"23","author":"Yang","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R74-7-20230208","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CNP72069","article-title":"Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephrotic syndrome.","volume":"72","author":"Sawara","year":"2009","journal-title":"Clin Nephrol"},{"key":"R75-7-20230208","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2169\/internalmedicine.48.2435","article-title":"Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome.","volume":"48","author":"Kurosu","year":"2009","journal-title":"Intern Med"},{"key":"R76-7-20230208","doi-asserted-by":"crossref","first-page":"c98","DOI":"10.1159\/000319656","article-title":"Effect of single-dose rituximab on primary glomerular diseases.","volume":"117","author":"Sugiura","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"R77-7-20230208","first-page":"308","article-title":"Rituximab for steroid-dependent nephrotic syndrome.","volume":"74","author":"Beco","year":"2010","journal-title":"Clin Nephrol"},{"key":"R78-7-20230208","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10157-011-0510-5","article-title":"Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome.","volume":"15","author":"Amemiya","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"R79-7-20230208","doi-asserted-by":"crossref","first-page":"c79","DOI":"10.1159\/000335142","article-title":"Rituximab treatment for adults with refractory nephrotic syndrome: A single-center experience and review of the literature.","volume":"120","author":"Kisner","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"R80-7-20230208","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(70)91093-7","article-title":"Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children.","volume":"1","author":"Abramowicz","year":"1970","journal-title":"Lancet"},{"key":"R81-7-20230208","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/adc.52.6.462","article-title":"Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood.","volume":"52","author":"Barratt","year":"1977","journal-title":"Arch Dis Child"},{"key":"R82-7-20230208","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archinte.1986.00360160169023","article-title":"Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids.","volume":"146","author":"Cade","year":"1986","journal-title":"Arch Intern Med"},{"key":"R83-7-20230208","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/PL00013436","article-title":"Efficacy of long-term azathioprine for relapsing nephrotic syndrome.","volume":"14","author":"Hiraoka","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"R84-7-20230208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/DDDT.S17521","article-title":"Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel.","volume":"5","author":"Bomback","year":"2011","journal-title":"Drug Des Devel Ther"},{"key":"R85-7-20230208","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000339287","article-title":"Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: A prospective trial.","volume":"36","author":"Bomback","year":"2012","journal-title":"Am J Nephrol"},{"key":"R86-7-20230208","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/ndt\/gfs035","article-title":"Saquinavir in steroid-dependent and -resistant nephrotic syndrome: A pilot study.","volume":"27","author":"Coppo","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R87-7-20230208","first-page":"75","article-title":"Plasma exchange in two cases of minimal change nephrotic syndrome with acute renal failure.","volume":"6","author":"Thysell","year":"1983","journal-title":"Int J Artif Organs"},{"key":"R88-7-20230208","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5414\/CNP65423","article-title":"Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy.","volume":"65","author":"Kobayashi","year":"2006","journal-title":"Clin Nephrol"},{"key":"R89-7-20230208","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00467-004-1460-x","article-title":"The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome.","volume":"19","author":"Lechner","year":"2004","journal-title":"Pediatr Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201305000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:22:36Z","timestamp":1786130556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201305000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2012070734","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}